 | By Lifenome Inc Joint venture combines AI-powered genomics with leading longevity care to bring precision health to Mexico and beyond.
|
 | By Ethos Collective We Picked The Wrong Hormone! Since the 1960s, doctors used estrogen to treat symptoms in women that were associated with a natural decrease in their sexual hormones. It was chosen for symptoms of ovarian failure.
|
By The Urban News Journal Urban chaos meets a health crisis in Marcus Hart's latest Urban News Journal episode, "Menopause Madness: Dementia's Sneak Attack on Women—Faith Fights Back," released March 13, 2025, on YouTube.
|
 | By RLA Publishing Letters to Zane, a deeply personal and eye-opening memoir about surviving Hyperemesis Gravidarum (HG), is now available for free to Kindle Unlimited subscribers.
|
By Sano Chemicals Sano Women's Health has received investigational new drug approval from the FDA, for Occidiofungin, a first-in-class novel peptide with broad antifungal activity.
|
 | By TLW Public Relations A portion of proceeds from cosmetics' sales will support programs for vulnerable women and girls.
|
By Hormonal Health Institute In a newly published clinical article, renowned hormone health expert Angela DeRosa, DO, MBA, CPE, raises critical concerns about the recently FDA-approved over-the-counter birth control pill, Opill, warning that healthcare providers and patients need to.
|
 | By Melinda Jackson Public Relations Best, Periodt., a revolutionary menstrual care company founded by Gayneté Jones, brings its innovative menstrual cups to CVS locations nationwide.
|
 | By CodyMD Start your lifelong conversation with Cody today. It's like chatting with your wicked smart trusty best friend.
|
 | By Human Touch Media Foundation Recent revelations of approximately 30,000 patients contracting hepatitis through contaminated blood transfusions in the UK shows there is an urgent need to address the importance of patient education, self-advocacy, informed consent, and awareness of...
|
By Sano Chemicals Sano Chemicals today announced the start of a Phase 1, first-in-human clinical trial, of Occidiofungin, a new chemical entity under development as a treatment to cure recurrent vulvovaginal candidiasis (RVVC).
|
By FemBridge FemBridge, an innovative maternal solutions organization committed to improving women's health, is pleased to announce the formalization of a Memorandum of Understanding (MOU) with HeraMED, a pioneer in innovative maternal and fetal technology company.
|
 | By Human Touch Media Foundation This month marked the annual meeting for the Society for the Advancement of Patient Blood Management (SABM) held at Gaylord Opryland Resort & Convention Center in Nashville, Tennessee sponsored by Vanderbilt University Medical Center.
|
 | By Cummings Graduate Institute Cummings Graduate Institute for Behavioral Health Studies (CGI) is immensely proud to host the 2023 Integrated Care Conference, Opportunity in Crisis - Using Adverse Pandemic Experiences to Drive Healthcare Improvement, featuring 48 presenters and 36...
|
 | By Human Touch Media Foundation HealthEd Australia held their Annual Women's & Children's Health Update 2023, at the Perth Convention & Exhibition Center (PCEC) on Saturday, August 12, 2023.
|
 | By Human Touch Media Foundation The title of the conference was "Paving the Path to a Bloodless Future".
|
By Melissa Kirkpatrick Coaching Empowering Her Women's Health Expo Sunday, May 21, 10am-2pm at The Summit Hotel to celebrate National Women's Health Week and benefit the YWCA of Greater Cincinnati
|
 | By The Association of Farmworker Opportunity Programs Join us to celebrate farmworker women's health during AFOP's NFWHW Awareness Campaign on May 14 -20, 2023.
|
